Information sur le cancer / Types de cancer / Rein / Traitement / Stade 2

Alberta Health Services. (2017, November). Renal Cell Carcinoma Clinical Practice Guideline GU-003. Extrait de: https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu003-renal-cell.pdf.

Karakiewicz PI, Zaffuto E, Kapoor A, et al. Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. (2018). Canadian Urological Association Journal. 12(6):173-180. Extrait de: https://www.kidneycancercanada.ca/media/1173898/2018-role-of-adjuvant-therapy-after-nephrectomy-eng.pdf.

Lane BR, Canter DJ, Rin BL, et al. Cancer of the kidney. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 63:865-884.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer (Version 2.2019). Extrait de: https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf.

Rendon RA, Kapoor A, Breau R, Leveridge M, Feifer A, Black PC, So A. Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus. (2014). Canadian Urological Association Journal. 8(5/6): e398-412. Extrait de: http://journals.sfu.ca/cuaj/index.php/journal/article/view/1894.